1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial

Authors:
  • HSH-C. Sun
    H-C. Sun
  • JFJ. Fan
    J. Fan
  • FSF. Shen
    F. Shen
  • JZJ. Zhou
    J. Zhou
  • TST. Song
    T. Song
  • XBX. Bai
    X. Bai
  • YZY. Zeng
    Y. Zeng
  • MCM. Chen
    M. Chen
  • ZHZ. Huang
    Z. Huang
  • MKM. Kuang
    M. Kuang
  • JCJ. Cai
    J. Cai
  • JGJ. Gao
    J. Gao

Abstract
No abstract available